InvestorsObserver
×
News Home

Will Poseida Therapeutics Inc (PSTX) Outperform the Rest of the Stocks in the Healthcare Sector?

Monday, October 23, 2023 10:06 AM | InvestorsObserver Analysts

Mentioned in this article

Will Poseida Therapeutics Inc (PSTX) Outperform the Rest of the Stocks in the Healthcare Sector?

Poseida Therapeutics Inc (PSTX) is around the top of the Healthcare sector according to InvestorsObserver. PSTX received an overall rating of 12, which means that it scores higher than 12% of stocks. Additionally, Poseida Therapeutics Inc scored a 74 in the Healthcare sector, ranking it higher than 74% of stocks in that sector.

Overall Score - 12
PSTX has an Overall Score of 12. Find out what this means to you and get the rest of the rankings on PSTX!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 12 means the stock is more attractive than 12 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Poseida Therapeutics Inc Stock Today?

Poseida Therapeutics Inc (PSTX) stock is trading at $2.16 as of 9:53 AM on Monday, Oct 23, a decline of -$0.19, or -8.1% from the previous closing price of $2.35. The stock has traded between $2.11 and $2.31 so far today. Volume today is below average. So far 56,053 shares have traded compared to average volume of 497,326 shares. Click Here to get the full Stock Report for Poseida Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App